Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 24;18(4):417-428.
doi: 10.1108/IJPH-06-2021-0056. Epub 2021 Dec 22.

A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users

Salim Mezaache  1 , Laélia Briand-Madrid  1 , Virginie Laporte  2 , Daniela Rojas Castro  3 , Patrizia Carrieri  4 , Perrine Roux  4
Affiliations

A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users

Salim Mezaache et al. Int J Prison Health. .

Abstract

Purpose: People who inject drugs (PWID) face multiple health problems, including infectious diseases and drug overdoses. Applying syndemic and risk environment frameworks, this paper aims to examine the co-occurrence and clustering of drug-related harms and their association with incarceration experience with or without in-prison drug injection.

Design/methodology/approach: The authors used data from a cross-sectional survey conducted in 2015 among 557 active opioid injectors. Self-reported data were collected through face-to-face or online questionnaires. They distinguished three harm categories, namely, viral infections, bacterial infections and overdoses, and built an index variable by summing the number of harm categories experienced, yielding a score from 0 to 3. Association between incarceration experience and co-occurrence of harms was modelled using a multinomial logistic regression.

Findings: Of the 557 participants, 30% reported lifetime experience of drug-related viral infection, 46% bacterial infection and 22% drug overdose. Multinomial logistic models showed that those who injected drugs during incarceration were more likely to report two (aOR = 2.35, 95% CI: 1.03-5.36) and three (aOR = 9.72, 95% CI: 3.23-29.22) harm categories than those who had never been incarcerated. They were also more likely to report three harm categories than formerly incarcerated respondents who did not inject drugs in prison (aOR = 5.14, 95% CI: 1.71-15.48).

Originality/value: This study provides insights of the syndemic nature of drug-related harms and highlights that drug injection during incarceration is associated with co-occurring harms. Public health interventions and policy changes are needed to limit the deleterious impact of prison on PWID.

Keywords: Bacterial infections; HCV; HIV; Injection drug use; Overdoses; Prison; Syndemic.

PubMed Disclaimer

References

    1. Aebi, M.F. and Tiago, M.M. (2020), SPACE I – 2019 – Council of Europe Annual Penal Statistics: Prison Population, Strasbourg: Council of Europe.
    1. Altice, F.L., Kamarulzaman, A., Soriano, V.V., Schechter, M. and Friedland, G.H. (2010), “Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs”, The Lancet, Vol. 376 No. 9738, pp. 367-387.
    1. Azbel, L., Wegman, M.P., Polonsky, M., Bachireddy, C., Meyer, J., Shumskaya, N., Kurmanalieva, A., et al. (2018), “Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments”, International Journal of Prisoner Health, Vol. 14 No. 3, pp. 175-187.
    1. Bates, M.C., Annie, F., Jha, A. and Kerns, F. (2019), “Increasing incidence of IV‐drug use associated endocarditis in Southern West Virginia and potential economic impact”, Clinical Cardiology, Vol. 42 No. 4, pp. 432-437.
    1. Colledge, S., Peacock, A., Leung, J., Larney, S., Grebely, J., Hickman, M., Cunningham, E., et al. (2019), “The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and Meta-analysis”, International Journal of Drug Policy, Vol. 73, pp. 172-184.

Publication types

Substances